Global Antidiarrheal Microorganisms Market Growth 2024-2030

Publication ID:

LPI10245605

Publication Date:

November 1, 2024

Pages:

136

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Antidiarrheal Microorganisms market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淎ntidiarrheal Microorganisms Industry Forecast鈥� looks at past sales and reviews total world Antidiarrheal Microorganisms sales in 2023, providing a comprehensive analysis by region and market sector of projected Antidiarrheal Microorganisms sales for 2024 through 2030. With Antidiarrheal Microorganisms sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antidiarrheal Microorganisms industry.
This Insight Report provides a comprehensive analysis of the global Antidiarrheal Microorganisms landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antidiarrheal Microorganisms portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Antidiarrheal Microorganisms market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antidiarrheal Microorganisms and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antidiarrheal Microorganisms.
United States market for Antidiarrheal Microorganisms is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Antidiarrheal Microorganisms is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Antidiarrheal Microorganisms is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Antidiarrheal Microorganisms players cover Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd., Zhejiang Jingxin Pharmaceutical Co., Ltd., Beijing Hanmei Pharmaceutical Co., Ltd., Livzon Pharmaceutical Factory of Livzon Group, Inner Mongolia Shuangqi Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Antidiarrheal Microorganisms market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Bacillus Licheniformis Live Bacteria
Bacillus Subtilis Live Bacteria
Bifidobacterium Live Bacteria
Other
Segmentation by Application:
Hospital
Clinic
Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd.
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Beijing Hanmei Pharmaceutical Co., Ltd.
Livzon Pharmaceutical Factory of Livzon Group
Inner Mongolia Shuangqi Pharmaceutical Co., Ltd.
Sinovac Biotech Co., Ltd.
Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
Jincheng Haisi Pharmaceutical Co., Ltd.
Hangzhou Yuanda Biopharmaceutical Co., Ltd.
Biofermin
Aptalis Pharma SAS
Pepto Bismol
Tangsonsbio
VWR
Vermicon AG
Chr. Hansen
Goerlich Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Antidiarrheal Microorganisms market?
What factors are driving Antidiarrheal Microorganisms market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antidiarrheal Microorganisms market opportunities vary by end market size?
How does Antidiarrheal Microorganisms break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antidiarrheal Microorganisms Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Antidiarrheal Microorganisms by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Antidiarrheal Microorganisms by Country/Region, 2019, 2023 & 2030
2.2 Antidiarrheal Microorganisms Segment by Type
2.2.1 Bacillus Licheniformis Live Bacteria
2.2.2 Bacillus Subtilis Live Bacteria
2.2.3 Bifidobacterium Live Bacteria
2.2.4 Other
2.3 Antidiarrheal Microorganisms Sales by Type
2.3.1 Global Antidiarrheal Microorganisms Sales Market Share by Type (2019-2024)
2.3.2 Global Antidiarrheal Microorganisms Revenue and Market Share by Type (2019-2024)
2.3.3 Global Antidiarrheal Microorganisms Sale Price by Type (2019-2024)
2.4 Antidiarrheal Microorganisms Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.4.4 Other
2.5 Antidiarrheal Microorganisms Sales by Application
2.5.1 Global Antidiarrheal Microorganisms Sale Market Share by Application (2019-2024)
2.5.2 Global Antidiarrheal Microorganisms Revenue and Market Share by Application (2019-2024)
2.5.3 Global Antidiarrheal Microorganisms Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Antidiarrheal Microorganisms Breakdown Data by Company
3.1.1 Global Antidiarrheal Microorganisms Annual Sales by Company (2019-2024)
3.1.2 Global Antidiarrheal Microorganisms Sales Market Share by Company (2019-2024)
3.2 Global Antidiarrheal Microorganisms Annual Revenue by Company (2019-2024)
3.2.1 Global Antidiarrheal Microorganisms Revenue by Company (2019-2024)
3.2.2 Global Antidiarrheal Microorganisms Revenue Market Share by Company (2019-2024)
3.3 Global Antidiarrheal Microorganisms Sale Price by Company
3.4 Key Manufacturers Antidiarrheal Microorganisms Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antidiarrheal Microorganisms Product Location Distribution
3.4.2 Players Antidiarrheal Microorganisms Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Antidiarrheal Microorganisms by Geographic Region
4.1 World Historic Antidiarrheal Microorganisms Market Size by Geographic Region (2019-2024)
4.1.1 Global Antidiarrheal Microorganisms Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Antidiarrheal Microorganisms Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Antidiarrheal Microorganisms Market Size by Country/Region (2019-2024)
4.2.1 Global Antidiarrheal Microorganisms Annual Sales by Country/Region (2019-2024)
4.2.2 Global Antidiarrheal Microorganisms Annual Revenue by Country/Region (2019-2024)
4.3 Americas Antidiarrheal Microorganisms Sales Growth
4.4 APAC Antidiarrheal Microorganisms Sales Growth
4.5 Europe Antidiarrheal Microorganisms Sales Growth
4.6 Middle East & Africa Antidiarrheal Microorganisms Sales Growth
5 Americas
5.1 Americas Antidiarrheal Microorganisms Sales by Country
5.1.1 Americas Antidiarrheal Microorganisms Sales by Country (2019-2024)
5.1.2 Americas Antidiarrheal Microorganisms Revenue by Country (2019-2024)
5.2 Americas Antidiarrheal Microorganisms Sales by Type (2019-2024)
5.3 Americas Antidiarrheal Microorganisms Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antidiarrheal Microorganisms Sales by Region
6.1.1 APAC Antidiarrheal Microorganisms Sales by Region (2019-2024)
6.1.2 APAC Antidiarrheal Microorganisms Revenue by Region (2019-2024)
6.2 APAC Antidiarrheal Microorganisms Sales by Type (2019-2024)
6.3 APAC Antidiarrheal Microorganisms Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antidiarrheal Microorganisms by Country
7.1.1 Europe Antidiarrheal Microorganisms Sales by Country (2019-2024)
7.1.2 Europe Antidiarrheal Microorganisms Revenue by Country (2019-2024)
7.2 Europe Antidiarrheal Microorganisms Sales by Type (2019-2024)
7.3 Europe Antidiarrheal Microorganisms Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antidiarrheal Microorganisms by Country
8.1.1 Middle East & Africa Antidiarrheal Microorganisms Sales by Country (2019-2024)
8.1.2 Middle East & Africa Antidiarrheal Microorganisms Revenue by Country (2019-2024)
8.2 Middle East & Africa Antidiarrheal Microorganisms Sales by Type (2019-2024)
8.3 Middle East & Africa Antidiarrheal Microorganisms Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antidiarrheal Microorganisms
10.3 Manufacturing Process Analysis of Antidiarrheal Microorganisms
10.4 Industry Chain Structure of Antidiarrheal Microorganisms
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antidiarrheal Microorganisms Distributors
11.3 Antidiarrheal Microorganisms Customer
12 World Forecast Review for Antidiarrheal Microorganisms by Geographic Region
12.1 Global Antidiarrheal Microorganisms Market Size Forecast by Region
12.1.1 Global Antidiarrheal Microorganisms Forecast by Region (2025-2030)
12.1.2 Global Antidiarrheal Microorganisms Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Antidiarrheal Microorganisms Forecast by Type (2025-2030)
12.7 Global Antidiarrheal Microorganisms Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd.
13.1.1 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Company Information
13.1.2 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolios and Specifications
13.1.3 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Main Business Overview
13.1.5 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Latest Developments
13.2 Zhejiang Jingxin Pharmaceutical Co., Ltd.
13.2.1 Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information
13.2.2 Zhejiang Jingxin Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolios and Specifications
13.2.3 Zhejiang Jingxin Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Zhejiang Jingxin Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Zhejiang Jingxin Pharmaceutical Co., Ltd. Latest Developments
13.3 Beijing Hanmei Pharmaceutical Co., Ltd.
13.3.1 Beijing Hanmei Pharmaceutical Co., Ltd. Company Information
13.3.2 Beijing Hanmei Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolios and Specifications
13.3.3 Beijing Hanmei Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Beijing Hanmei Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Beijing Hanmei Pharmaceutical Co., Ltd. Latest Developments
13.4 Livzon Pharmaceutical Factory of Livzon Group
13.4.1 Livzon Pharmaceutical Factory of Livzon Group Company Information
13.4.2 Livzon Pharmaceutical Factory of Livzon Group Antidiarrheal Microorganisms Product Portfolios and Specifications
13.4.3 Livzon Pharmaceutical Factory of Livzon Group Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Livzon Pharmaceutical Factory of Livzon Group Main Business Overview
13.4.5 Livzon Pharmaceutical Factory of Livzon Group Latest Developments
13.5 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd.
13.5.1 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Company Information
13.5.2 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolios and Specifications
13.5.3 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Latest Developments
13.6 Sinovac Biotech Co., Ltd.
13.6.1 Sinovac Biotech Co., Ltd. Company Information
13.6.2 Sinovac Biotech Co., Ltd. Antidiarrheal Microorganisms Product Portfolios and Specifications
13.6.3 Sinovac Biotech Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Sinovac Biotech Co., Ltd. Main Business Overview
13.6.5 Sinovac Biotech Co., Ltd. Latest Developments
13.7 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
13.7.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
13.7.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolios and Specifications
13.7.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Latest Developments
13.8 Jincheng Haisi Pharmaceutical Co., Ltd.
13.8.1 Jincheng Haisi Pharmaceutical Co., Ltd. Company Information
13.8.2 Jincheng Haisi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolios and Specifications
13.8.3 Jincheng Haisi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Jincheng Haisi Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Jincheng Haisi Pharmaceutical Co., Ltd. Latest Developments
13.9 Hangzhou Yuanda Biopharmaceutical Co., Ltd.
13.9.1 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Company Information
13.9.2 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolios and Specifications
13.9.3 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Main Business Overview
13.9.5 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Latest Developments
13.10 Biofermin
13.10.1 Biofermin Company Information
13.10.2 Biofermin Antidiarrheal Microorganisms Product Portfolios and Specifications
13.10.3 Biofermin Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Biofermin Main Business Overview
13.10.5 Biofermin Latest Developments
13.11 Aptalis Pharma SAS
13.11.1 Aptalis Pharma SAS Company Information
13.11.2 Aptalis Pharma SAS Antidiarrheal Microorganisms Product Portfolios and Specifications
13.11.3 Aptalis Pharma SAS Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Aptalis Pharma SAS Main Business Overview
13.11.5 Aptalis Pharma SAS Latest Developments
13.12 Pepto Bismol
13.12.1 Pepto Bismol Company Information
13.12.2 Pepto Bismol Antidiarrheal Microorganisms Product Portfolios and Specifications
13.12.3 Pepto Bismol Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Pepto Bismol Main Business Overview
13.12.5 Pepto Bismol Latest Developments
13.13 Tangsonsbio
13.13.1 Tangsonsbio Company Information
13.13.2 Tangsonsbio Antidiarrheal Microorganisms Product Portfolios and Specifications
13.13.3 Tangsonsbio Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Tangsonsbio Main Business Overview
13.13.5 Tangsonsbio Latest Developments
13.14 VWR
13.14.1 VWR Company Information
13.14.2 VWR Antidiarrheal Microorganisms Product Portfolios and Specifications
13.14.3 VWR Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 VWR Main Business Overview
13.14.5 VWR Latest Developments
13.15 Vermicon AG
13.15.1 Vermicon AG Company Information
13.15.2 Vermicon AG Antidiarrheal Microorganisms Product Portfolios and Specifications
13.15.3 Vermicon AG Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Vermicon AG Main Business Overview
13.15.5 Vermicon AG Latest Developments
13.16 Chr. Hansen
13.16.1 Chr. Hansen Company Information
13.16.2 Chr. Hansen Antidiarrheal Microorganisms Product Portfolios and Specifications
13.16.3 Chr. Hansen Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Chr. Hansen Main Business Overview
13.16.5 Chr. Hansen Latest Developments
13.17 Goerlich Pharma
13.17.1 Goerlich Pharma Company Information
13.17.2 Goerlich Pharma Antidiarrheal Microorganisms Product Portfolios and Specifications
13.17.3 Goerlich Pharma Antidiarrheal Microorganisms Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Goerlich Pharma Main Business Overview
13.17.5 Goerlich Pharma Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂